Mycobacterium avium complex infection Recruiting Phase 2 / 3 Trials for Azithromycin (DB00207)

Back to Mycobacterium avium complex infection

Also known as: Mycobacterium Avium Complex (MAC) / MAC / Mycobacterium Avium Complex / Mycobacterium avium-intracellulare Infection / Mycobacterium avium intracellulare infection / Infection mycobacterium avium / Mycobacterium avium intracellulare / Battey disease (disorder) / Infection caused by Mycobacterium intracellulare (disorder) / Complement C9 / Active C5b6789 (substance) / Terminal complement complex SC5b-9, vitronectin complexed with C5b-9 (substance) / Complement Membrane Attack Complex / Mycobacterium, MAIS group / Mycobacterium, avium-intracellulare group (organism) / Mycobacterium test / Mycobacteria test

Indication	Status	Phase
DBCOND0013995 (Mycobacterium avium complex infection)	Recruiting	2 / 3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03672630	Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease	Treatment	Azithromycin (DB00207) Ethambutol (DB00330) Rifampicin (DB01045)